Last reviewed · How we verify
Sonovue, Bracco
At a glance
| Generic name | Sonovue, Bracco |
|---|---|
| Sponsor | Rambam Health Care Campus |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency (PHASE1)
- Placenta Accreta : Contrast-enhanced Ultrasound Analysis in High Risk Population (NA)
- 3D Contrast Enhanced Microvascular Ultrasound of Carotid Atherosclerosis for the Detection of Carotid Plaque Neo-Revascularisation. (NA)
- Carotid Atherosclerosis : Innovative Imaging Biomarkers. Study Case-control (NA)
- Ultrafast Ultrasound Imaging Assesment of Carotid Plaque Neovascularization (NA)
- Multi-parametric Ultrasound Versus Multi-parametric MRI for Prostate Cancer Detection (NA)
- Multicentered Prospective Randomized Controlled Trial For Solid Pancreatic Lesions (NA)
- Usefulness of Contrast Enhanced Harmonic Endoscopic Ultrasound for Pancreatic Cysts (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sonovue, Bracco CI brief — competitive landscape report
- Sonovue, Bracco updates RSS · CI watch RSS
- Rambam Health Care Campus portfolio CI